Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0000875320-26-000129 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-03 | 2026-02-27 | VRTX | Kewalramani Reshma | CEO, Pres, Dir | S - Sale | $493.47 | -40.0K | 106.0K | -27% | -$19.74M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-27 | S | D | 3,278 | $488.27 | 131,730 | D | — | — | (F7) Open market sales reported on this line occurred at a weighted average price of $488.27 (range $487.82 to $488.56). (F2) Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2026-02-27 | S | D | 2,510 | $487.13 | 135,008 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $487.13 (range $486.64 to $487.55). (F2) Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2026-02-27 | S | D | 240 | $482.84 | 137,518 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $482.84 (range $482.84 to $482.85). (F2) Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2026-02-27 | S | D | 120 | $481.50 | 137,758 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $481.50 (range $481.50 to $481.51). (F2) Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2026-02-27 | S | D | 400 | $479.75 | 137,878 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $479.75 (range $479.75 to $479.76). (F2) Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2026-02-27 | S | D | 460 | $489.32 | 131,270 | D | — | — | (F8) Open market sales reported on this line occurred at a weighted average price of $489.32 (range $489.01 to $489.79). (F2) Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2026-02-27 | S | D | 1,725 | $496.95 | 98,278 | D | — | — | (F15) Open market sales reported on this line occurred at a weighted average price of $496.95 (range $496.79 to $497.17). (F2) Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 8 | Common | Common Stock | 2026-02-27 | S | D | 5,995 | $496.16 | 100,003 | D | — | — | (F14) Open market sales reported on this line occurred at a weighted average price of $496.16 (range $495.79 to $496.74). (F2) Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 9 | Common | Common Stock | 2026-02-27 | S | D | 2,725 | $490.54 | 128,545 | D | — | — | (F9) Open market sales reported on this line occurred at a weighted average price of $490.54 (range $490.10 to $491.01). (F2) Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 10 | Common | Common Stock | 2026-02-27 | S | D | 949 | $491.30 | 127,596 | D | — | — | (F10) Open market sales reported on this line occurred at a weighted average price of $491.30 (range $491.13 to $491.85). (F2) Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 11 | Common | Common Stock | 2026-02-27 | S | D | 2,520 | $493.29 | 125,076 | D | — | — | (F11) Open market sales reported on this line occurred at a weighted average price of $493.29 (range $492.78 to $493.77). (F2) Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 12 | Common | Common Stock | 2026-02-27 | S | D | 3,498 | $494.33 | 121,578 | D | — | — | (F12) Open market sales reported on this line occurred at a weighted average price of $494.33 (range $493.78 to $494.75). (F2) Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 13 | Common | Common Stock | 2026-02-27 | S | D | 15,580 | $495.38 | 105,998 | D | — | — | (F13) Open market sales reported on this line occurred at a weighted average price of $495.38 (range $494.79 to $495.78). (F2) Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |